We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GVH:NASDAQGlobavend Holdings Limited - Ord Shares Analysis

Data as of 2026-04-07 - not real-time

$2.33

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Globavend Holdings is trading at a steep discount, with a trailing P/E of 1.45 versus an industry average of 29.7, and a DCF‑derived fair value of $5.57 implying an upside of roughly 887%. The stock’s price of $2.33 sits just below the short‑term resistance around $2.80 and above the support near $0.87, while volume is on an increasing trend, supporting the recent bullish MACD crossover (MACD line $0.26 above signal $0.09). Technical momentum is mixed: the 20‑day SMA ($1.35) is above the 50‑day SMA ($1.23) but far below the 200‑day SMA ($10.77), and the RSI of 68 signals the stock is nearing overbought territory. Fundamentally, the company posted a 20.7% revenue growth year‑over‑year, yet margins remain thin (gross margin ~10%, operating margin ~1.7%, profit margin ~2.9%). Cash on hand exceeds $7.5 million while debt is negligible, though free cash flow is currently negative. The market cap is tiny at about $5.3 million, the beta is low (≈0.27) but 30‑day volatility is extreme at over 188%, underscoring liquidity and price‑swing risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and rising volume suggest short‑term buying pressure
  • RSI near 70 indicates potential near‑term overbought condition
  • Extreme 30‑day volatility and thin market cap raise downside risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Massive valuation gap (P/E 1.45 vs industry 29.7) and DCF upside
  • Solid revenue growth of 20.7% with minimal debt
  • Low beta indicating limited systematic risk

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable cash position and potential for margin improvement
  • Strategic position in cross‑border e‑commerce logistics across APAC
  • Long‑term undervaluation relative to peers and growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth20.70%
Profit Margin2.90%
P/E Ratio1.4
ROE8.98%
ROA6.25%
Debt/Equity0.31
P/B Ratio0.4
Op. Cash Flow$240.4K
Free Cash Flow$-191277
Industry P/E29.7

Technical Analysis

TrendNeutral
RSI67.9
Support$0.87
Resistance$2.80
MA 20$1.35
MA 50$1.23
MA 200$10.77
MACDBullish
VolumeIncreasing
Fear & Greed Index77.55

Valuation

Fair Value$5.57
Target Price$23.00
Upside/Downside887.12%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.27
Volatility188.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.